stockrow
Tuesday 3 November 2026
Export MOH’s income statement to Excel — free account
Molina Healthcare, Inc
MOH Healthcare Healthcare Plans
Molina Healthcare, Inc’s revenue for fiscal 2025 (year ended December 2025) was $45.4 billion, up 11.7% from fiscal 2024.
- Revenue
- −3.44%
- EPS
- −51.7%
- Free cash flow
- −20.3%
- Total debt
- +2.54%
Quarter to September 2026, against a year earlier
207.78
0.67
−0.32%
Follow MOH
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
20.27 | 14.25 | 19.78 | 23.54 | 28.27 | 18.94 | 11.83 | 11.00 | 0.00 | 58.10 |
Piotroski F-Score |
4 | 5 | 8 | 8 | 6 | 5 | 4 | 5 | 3 | 4 |
Altman Z-Score |
4.28 | 4.60 | 4.53 | 4.77 | 4.27 | 4.06 | 4.88 | 4.50 | 2.82 | 3.21 |
P/S ratio |
0.20 | 0.41 | 0.63 | 0.58 | 0.66 | 0.65 | 0.50 | 0.38 | 0.22 | 0.17 |
P/FCF ratio |
0.00 | 30.71 | 13.59 | 27.03 | 9.00 | 6.88 | 22.39 | 0.00 | 6.08 | 5.97 |
Altman Z″-Score (non-manufacturers) |
3.60 | 4.06 | 3.90 | 3.43 | 3.11 | 3.70 | 4.92 | 3.87 | 1.38 | 2.18 |
Beneish M-Score |
(1.99) | (2.15) | (2.41) | (2.41) | (2.59) | (2.55) | (2.06) | (1.48) | (3.45) | (2.29) |
P/Operating CF |
(30.75) | (74.58) | (31.07) | (86.95) | 30.80 | 9.66 | 234.44 | (57.64) | (28.55) | 74.22 |
P/B ratio |
2.25 | 3.72 | 5.09 | 6.22 | 6.99 | 5.99 | 4.31 | 4.30 | 3.27 | 1.80 |
Price to Tangible BV |
4.89 | 6.53 | 7.75 | 11.71 | 13.34 | 10.86 | 4.72 | 4.87 | 4.04 | 3.34 |
EV/Sales |
0.11 | 0.27 | 0.43 | 0.42 | 0.47 | 0.46 | 0.33 | 0.21 | 0.03 | 0.00 |
EV/EBITDA |
5.00 | 5.74 | 8.45 | 9.89 | 11.44 | 7.63 | 4.88 | 3.21 | 0.00 | 0.08 |
EV/Operating CF |
(9.13) | 16.87 | 8.87 | 17.26 | 6.21 | 4.69 | 12.74 | (12.87) | 0.82 | 0.05 |
EV/FCF |
(7.68) | 19.97 | 9.34 | 19.57 | 6.45 | 4.88 | 14.66 | (11.75) | 0.92 | 0.07 |
Quick Ratio |
1.60 | 1.56 | 1.50 | 1.43 | 1.39 | 1.55 | 1.78 | 1.37 | 1.21 | 1.22 |
Current Ratio |
1.69 | 1.62 | 1.54 | 1.47 | 1.43 | 1.59 | 1.83 | 1.52 | 1.35 | 1.31 |
Net Debt/EBITDA |
(4.41) | (3.10) | (3.85) | (3.79) | (4.56) | (3.15) | (2.59) | (2.42) | 10.75 | (6.01) |
Debt/Assets |
25.38% | 19.95% | 16.02% | 19.42% | 19.59% | 24.67% | 21.63% | 20.38% | 25.61% | 22.08% |
Debt/Equity |
0.97 | 0.69 | 0.57 | 0.81 | 0.91 | 1.12 | 0.75 | 0.89 | 1.62 | 1.00 |
Asset Turnover |
2.91 | 2.66 | 2.50 | 2.61 | 2.55 | 2.38 | 2.41 | 2.42 | 2.50 | 2.54 |
Operating CF/Net income |
(1.13) | 0.55 | 1.52 | 0.98 | 3.22 | 2.82 | 0.59 | (0.44) | (1.57) | 12.94 |
Capex/Depreciation |
(0.52) | (0.54) | (0.49) | (0.52) | (0.59) | (0.84) | (0.64) | (0.24) | (0.41) | (0.97) |
Interest Coverage |
4.07 | 14.47 | 14.43 | 10.66 | 8.50 | 10.57 | 12.00 | 9.83 | (4.70) | 3.03 |
| 11.02% | 27.07% | 30.39% | 28.32% | 27.89% | 33.19% | 40.86% | 47.39% | (34.29%) | 3.24% | |
| 3.03% | 7.73% | 8.02% | 6.46% | 6.06% | 8.25% | 10.57% | 9.05% | (6.43%) | 0.74% | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
8.78% | 22.83% | 23.49% | 22.71% | 19.31% | 20.38% | 23.91% | 28.77% | (22.30%) | 2.78% |
Average Days of Receivables |
28.39 | 29.62 | 33.25 | 26.28 | 28.61 | 31.42 | 30.49 | 25.70 | 15.99 | 20.79 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
6.62% | 6.75% | 7.23% | 7.23% | 7.45% | 7.62% | 7.70% | 7.06% | 8.02% | 7.83% |
Intangible Assets out of Total Assets |
0.14 | 0.12 | 0.10 | 0.11 | 0.10 | 0.10 | 0.03 | 0.03 | 0.03 | 0.10 |
Share Based Compensation of Revenue |
0.10% | 0.29% | 0.34% | 0.32% | 0.26% | 0.29% | 0.23% | 0.14% | 0.23% | 0.15% |
Graham Net Nets |
0.10 | 0.10 | 0.09 | 0.04 | 0.03 | 0.04 | 0.14 | 0.13 | 0.09 | 0.06 |
Graham Number |
121.83 | 189.75 | 175.69 | 125.04 | 107.32 | 94.74 | 90.18 | 80.13 | 0.00 | 24.85 |
Earnings Yield |
4.93% | 7.02% | 5.05% | 4.25% | 3.54% | 5.28% | 8.45% | 9.09% | (11.56%) | 1.72% |
Free Cash Flow Yield |
(6.94%) | 3.26% | 7.36% | 3.70% | 11.11% | 14.54% | 4.47% | (4.85%) | 16.44% | 16.74% |
Revenue per Share |
860.34 | 708.19 | 590.50 | 553.18 | 480.47 | 329.20 | 270.56 | 309.67 | 355.05 | 320.97 |
Operating CF per Share |
(10.13) | 11.22 | 28.80 | 13.37 | 36.66 | 32.17 | 6.98 | (5.15) | 14.36 | 12.15 |
Capex per Share |
(1.91) | (1.74) | (1.46) | (1.57) | (1.33) | (1.25) | (0.92) | (0.49) | (1.54) | (3.18) |
Free Cash Flow per Share |
(12.05) | 9.48 | 27.35 | 11.80 | 35.33 | 30.92 | 6.06 | (5.64) | 12.82 | 8.97 |
Cash per Share |
156.36 | 156.57 | 157.83 | 129.84 | 132.18 | 102.19 | 70.71 | 73.89 | 104.98 | 82.62 |
Shareholders Equity per Share |
77.06 | 78.33 | 73.05 | 51.28 | 45.50 | 35.53 | 31.51 | 27.00 | 23.88 | 29.77 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
77.06 | 78.33 | 73.05 | 51.28 | 45.50 | 35.53 | 31.51 | 27.00 | 23.88 | 29.77 |
Free Cash Flow |
(636.00) | 544.00 | 1,578.00 | 682.00 | 2,042.00 | 1,824.00 | 377.00 | (344.00) | 718.00 | 497.00 |
Working Capital |
5,072.00 | 4,877.00 | 4,374.00 | 3,229.00 | 3,017.00 | 2,911.00 | 2,698.00 | 2,216.00 | 1,954.00 | 1,418.00 |
Capital Expenditures |
(101.00) | (100.00) | (84.00) | (91.00) | (77.00) | (74.00) | (57.00) | (30.00) | (86.00) | (176.00) |
Net Current Asset Value |
949.00 | 1,639.00 | 1,865.00 | 734.00 | 485.00 | 440.00 | 1,140.00 | 955.00 | 377.00 | 188.00 |
EV/EBIT |
6.25 | 6.36 | 9.37 | 11.38 | 12.90 | 8.25 | 5.29 | 3.57 | 0.00 | 0.12 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Price to Operating Income |
11.73 | 9.79 | 13.63 | 15.71 | 18.02 | 11.64 | 8.08 | 6.27 | 0.00 | 9.70 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.65 | 0.65 | 0.63 | 0.68 | 0.33 | 0.23 | 0.23 | 0.53 | 0.61 | 0.40 |
Cash ROIC |
(3.91%) | 3.28% | 10.05% | 5.30% | 16.13% | 17.41% | 4.82% | (4.52%) | 7.65% | 6.31% |
Accounts Receivable Turnover |
13.30 | 12.70 | 12.61 | 14.28 | 14.43 | 12.62 | 12.30 | 17.16 | 21.11 | 21.91 |
Accounts Payable Turnover |
32.58 | 26.66 | 26.78 | 31.40 | 31.97 | 27.68 | 31.18 | 41.01 | 46.78 | 40.85 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
10.10 | 14.11 | 15.94 | 11.94 | 12.97 | 14.79 | 13.18 | 9.18 | 7.61 | 9.21 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
3,416.00 | 3,201.50 | 2,703.00 | 2,239.50 | 1,924.50 | 1,539.00 | 1,368.00 | 1,100.50 | 942.00 | 811.50 |
Average Payables |
1,212.00 | 1,291.50 | 1,070.50 | 865.50 | 741.50 | 571.50 | 446.00 | 378.00 | 375.50 | 373.50 |
Average Assets |
15,597.00 | 15,261.00 | 13,603.00 | 12,261.50 | 10,870.50 | 8,159.50 | 6,970.50 | 7,812.50 | 7,960.00 | 7,012.50 |
Average Common Equity |
4,282.50 | 4,355.50 | 3,589.50 | 2,797.00 | 2,363.00 | 2,028.00 | 1,803.50 | 1,492.00 | 1,493.00 | 1,603.00 |
Columns are period end dates · fundamentals updated 2 Nov 2026